虾肉中呋喃它酮代谢物化学发光酶免疫分析方法的建立

采用对碘苯酚增强的HRP-鲁米诺-H2O2化学发光体系,建立了虾肉中呋喃它酮代谢物5-吗啉甲基-3-氨基-2-恶唑烷基酮(AMOZ)残留的间接竞争化学发光酶免疫分析(icCLEIA)检测方法。检测所用抗体是基因重组的抗AMOZ衍生物单链抗体。优化的icCLEIA最佳工作条件为:AMOZA-OVA包被浓度62.5μg/L,抗AMOZ衍生物单链抗体最佳稀释度为1∶10,竞争免疫反应时间45 min,HRP酶标记羊抗鼠抗体最佳稀释度为1∶10000,孵育时间50 min。本方法的IC50为1.38μg/L;灵敏度为0.09μg/L;线性范围为0.26～9.08μg/L(IC20～IC80);批内和批间相对标准偏差均小于15%;抗AMOZ衍生物单链抗体与其它硝基呋喃类抗生素及其代谢物均没有交叉反应,特异性良好。4个不同添加量的AMOZ加标样品的平均回收率分别为72.2%,73.4%,72.6%和78.6%。与HPLC-MS/MS法测定值进行比较发现,两种方法相关性良好(R2=0.9997)。本方法可用于水产品中AMOZ残留的快速检测。     

基于间接竞争原理的流式微球技术快速检测麦芽中赭曲霉毒素A

建立了一种快速、灵敏检测中药麦芽中赭曲霉毒素A(Ochratoxin A,OTA)含量的间接竞争流式微球方法.麦芽样品经60％甲醇/PBS提取,加入20％甲醇/PBS溶液稀释5倍后,离心取上清液制备样品.在编码荧光微球上偶联牛血清白蛋白-OTA(BSA-OTA)复合物,与样品中OTA竞争结合抗OTA特异性抗体,然后加入FITC-IgG孵育,离心洗涤后,用流式细胞仪检测微球表面的平均荧光强度,实现样品中OTA的准确定性定量测定.本方法检测OTA的半数抑制浓度IC50为1.20 ng/mL,相关系数R2=0.9892,检出限(IC10)为0.12 ng/mL,加样回收率为93.9％ ～ 97.4％,RSD＜3.6％.16份实际麦芽样品中检测到2个阳性样品,OTA的最高含量为3.83 μg/kg,未超出欧盟的OTA限量标准,与液相色谱-串联质谱(LC-MS/MS)法检测结果相一致.本方法简单、快速、灵敏、可靠,可拓展用于其它复杂基质中多种真菌毒素的定性与定量检测.     

保健食品中西地那非化学发光免疫分析方法研究

针对保健食品中西地那非药物的非法添加问题,该研究采用辣根过氧化物酶（HRP）与鲁米诺为信号输出系统,结合直接竞争模式探索了保健食品中西地那非的直接竞争化学发光酶免疫分析方法。基于特异性多克隆抗体,通过逐步优化策略,确定最佳免疫分析条件为：包被原质量浓度为41.67 ng/mL,酶标抗体质量浓度为1.25 μg/mL,封闭液和洗涤液的吐温－20含量为0.05%,稀释液的甲醇添加量为5%,竞争反应时间为40 min。在该条件下,建立了西地那非的直接竞争化学发光免疫分析方法,该方法对西地那非的半抑制浓度（IC50）为0.17 ng/mL,线性检测范围（IC20～IC80）为0.024 ~ 1.21 ng/mL,检出限（IC10,LOD）为0.008 ng/mL。与他达那非等功能类似物无显著交叉;西地那非样品的加标回收率为82.0%～114%,相对标准偏差均小于15%。盲样检测结果与HPLC－MS/MS确证方法具有良好一致性,说明该方法准确可靠,适用于样品中西地那非的快速筛查。     

基于多肽微阵列芯片的荧光和共振光散射法筛选凝血酶抑制剂

研制了一种基于多肽微阵列芯片的荧光和共振光散射双通路检测方法,对血液样品中的凝血酶抑制剂进行检测。以生物素化的多肽微阵列芯片为反应平台,加入凝血酶水解多肽上的特异位点使其C末端的生物素解离,通过亲和素和生物素之间的特异性结合,用荧光探针和30 nm金纳米粒子探针标记此反应过程。凝血酶抑制剂阻止凝血酶对底物多肽的水解反应,通过荧光和共振光散射信号强度的变化检测抑制剂的抑制能力。酶溶液和加标人血清中测定的半抑制浓度(IC50)值:阿加曲班<抗凝血酶Ⅲ<4-(2-氨乙基)苯磺酰氟盐酸盐,IC50差的绝对值随抑制剂特异性的减弱而增大。当抑制剂浓度为7.5μmol/L时,血浆中5种化合物的抑制能力:阿加曲班>抗凝血酶Ⅲ>胰蛋白酶抑制剂>N-(反式-环氧丁二酰基)-L-亮氨酸-4-胍基丁基酰胺>4-(2-氨乙基)苯磺酰氟盐酸盐。在血浆中考察了阿加曲班和抗凝血酶Ⅲ的可逆性。对比荧光法和共振光散射法在血液样品中的检测结果,用30 nm金纳米粒子标记的共振光散射法更适用于复杂血液样品中抑制剂的检测     

葛根中抑制磷酸二酯酶4活性成分的筛选研究

实验选取与抗炎免疫密切相关的磷酸二酯酶4为靶点,应用超滤液质联用技术和酶体外活性抑制实验筛选并鉴定了葛根中抑制磷酸二酯酶4活性成分.实验结果表明葛根提取物具有抑制磷酸二酯酶4的作用,IC50值为0.04g/L.葛根素抑制磷酸二酯酶4作用最强,其次为大豆苷和大豆苷元,IC50值分别为52.79,71.54和122.17μmol/L.超滤液质联用实验筛选结果与体外活性实验一致.3′-羟基葛根素和3′-甲氧基葛根素在2个实验中均没有抑制磷酸二酯酶4的作用.     

超高效液相串联质谱法同时定量检测6个细胞色素P450酶探针代谢产物

应用超高效液相色谱-质谱联用技术(LC-MS/MS),建立了同时定量测定6个细胞色素P450酶(CYP)探针代谢产物的方法。用甲醇和乙腈混合溶剂沉淀肝微粒体孵育液中的蛋白,在ZORBAX-C18色谱柱(100 mm×4.6 mm,3.5μm)上,以5 mmol/L甲酸铵和0.1%甲酸-乙腈为流动相,梯度分离待测物。在串联质谱正离子多反应监测模式下定量检测待测物。方法学验证结果表明,6个代谢产物在1.0～1000.0μg/L的范围内均呈良好的线性关系(r2>0.994);定量限为1μg/L;方法的日内和日间精密度(RSD)均小于12%;加标回收率为92.8%～104.4%;不同储存条件下样品稳定性实验的浓度偏差(RSD)小于10%。人肝微粒体活性测定的结果显示CYP1A2和CYP3A4的酶活性最强,分别为(466.1±32.1)和(694.3±11.7)pmole/(mg.min),与最低的CYP2C19酶活性分别相差27.7和41.3倍。本方法简便、快速、灵敏,适用于大量化合物CYP酶诱导和抑制评价的酶活性测定。     

液相色谱-质谱联用技术结合多探针底物法研究人参皂苷Rb1的体外代谢

以奥美拉唑、 苯妥英、 卡马西平和非那西丁为检测肝药酶细胞色素P450酶(CYP450)亚型的专属探针药物, 通过原型药物减少量测定法考察药物体外代谢的变化, 评价人参皂苷Rb1对CYP450不同亚型酶的作用. 结果表明, P2C9, P2C19和P3A4实验组与对照组差异不显著, P1A2实验组与对照组差异显著, 表明人参皂苷Rb1能诱导P1A2亚型酶的活性, 促进底物与酶反应, 加快底物的代谢, 而对P2C9, P2C19和P3A4三个亚型酶有弱的诱导或无诱导作用. 根据快速分离液相色谱-质谱联用(RRLC-MS/MS)检测结果推断, 人参皂苷Rb1在CYP450酶中的代谢产物可转化为人参皂苷Rb1氧化产物(Rb1+O)及人参皂苷Rd和F2.     

具噻吩环8-去氮杂叶酸类似物的合成及生物活性研究

根据叶酸代谢中蛋氨酸合成酶的作用机理和二氢叶酸还原酶抑制剂的结构特点,设计噻吩取代苯环的8-去氮杂叶酸类似物作为双靶点抑制剂.以噻吩-2-甲酸为原料,与谷氨酸二乙酯连接后经过硝化、还原、缩合、水解,得到两个目标化合物,经1H NMR,13C NMR和MS对化合物的结构进行了表征.初步生物活性结果表明,此类化合物对两种酶都有一定的抑制作用,其中一个化合物对蛋氨酸合成酶的抑制IC50为25.2μmol/L,对二氢叶酸还原酶的抑制IC50为2.3μmol/L.     

DART-Q-TOF质谱法对左金丸的快速定性分析

运用实时直接分析离子源与四极杆-飞行时间质谱联用技术,建立了对中成药左金丸中化学成分快速定性分析的方法。左金丸经乙醇超声提取后,置于离子源和质谱处,采用Full MS和Targeted MS/MS扫描方式采集信号,通过对照品与样品一级、二级质谱图以及文献的比对,快速鉴别出左金丸中5种化学成分。该方法可应用于中药复杂体系多成分的快速定性分析。     

用高表达EGFR细胞膜色谱-HPLC/MS联用快速筛选独活中抗EGFR活性成分

报道了用高表达表皮生长因子受体细胞膜色谱与高效液相色谱/质谱在线联用方法(EGFR/CMC-online-HPLC/MS)快速筛选发现中药独活中的活性成分.实验中,采用高表达EGFR的细胞膜制备色谱固定相,建立EGFR/细胞膜色谱(EGFR/CMC)模型,利用柱切换和固相萃取技术,将EGFR/CMC模型与高效液相色谱/质谱(HPLC/MS)在线联用,构成一种新的可同时"识别-鉴定"目标成分的二维色谱系统,并应用于快速筛选独活中具有抗EGFR活性的目标成分.结果发现独活中的蛇床子素具有与对照药物达沙替尼类似的色谱保留特性,能够作用于EGFR;同时MTT及Elisa分析实验证实蛇床子素对HEK293EGFR细胞增殖及EGFR表达均有抑制作用.本文建立的EGFR/CMC-online-HPLC/MS二维色谱方法,可以选择性地从中药复杂体系中快速"识别-鉴定"目标组分,且筛选结果与特定生物效应显著相关.     

Development of a quantitative FI-MS technique for the characterization of high- and nonboiling saturated hydrocarbon mixtures

Summary Using a saturated non-boiling hydrocarbon mixture, the influence of two parameters on the results of field ionization mass spectrometry (FI-MS) measurements was studied: (a) the potential difference between the FI emitter and the counterelectrode; (b) the emitter temperature.Variation of the potential difference had only a minor effect on the average molecular mass measured and had no evident effect on the relative ring number distribution in the sample. In contrast, when the emitter temperature was increased, higher average molecular masses were recorded. Moreover, the average molecular masses shifted to higher ring numbers. In order to control the relationship between the described influences during mixture analysis, measuring instructions have been developed that enable the quantitative analysis of unknown saturated samples. However, average molecular mass of the mixture must be known.

---

Entwicklung einer quantitativen FI-MS-Methode zur Charakterisierung von gesättigten hoch- und nichtsiedenden Kohlenwasserstoffgemischen

     

Flow injection mass spectroscopic fingerprinting and multivariate analysis for differentiation of three Panax species

This study describes the use of spectral fingerprints acquired by flow injection(FI)-MS and multivariate analysis to differentiate three Panax species: P. ginseng, P. quinquefolius, and P. notoginseng. Data were acquired using both high resolution and unit resolution MS, and were processed using principal component analysis (PCA), soft independent modeling of class analogy (SIMCA), partial least squares-discriminant analysis (PLS-DA), and a fuzzy rule-building expert system (FuRES). Both high and unit resolution MS allowed discrimination among the three Panax species. PLS-DA and FuRES provided classification with 100% accuracy while SIMCA provided classification accuracies of 77 and 88% by high- and low-resolution MS, respectively. The method does not quantify any of the sample components. With FI-MS, the analysis time was less than 2 min.     

Sulfation of hesperetin,naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis

Abstract

Previous studies have revealed sulfation as a major pathway for the metabolism of hesperetin, naringenin and apigenin. The current study was designed to identify the human cytosolic sulfotransferase (SULT) enzyme(s) capable of sulfating these flavonoid compounds. Of the thirteen human SULTs, six (1A1, 1A2, 1A3, 1B2, 1C4, 1E1) displayed significant sulfating activity toward hesperetin, five (1A1, 1A2, 1A3, 1B2, 1C4) displayed sulfating activity towards naringenin, and four (1A1, 1A2, 1A3, 1C4) showed sulfating activity towards apigenin. Of the four human organ specimens tested, liver and intestine cytosols displayed much higher hesperetin-, naringenin- and apigenin-sulfating activity than lung and kidney cytosols. Moreover, sulfation of hesperetin, naringenin and apigenin was shown to take place in HepG2 human hepatoma cells and Caco-2 human colon adenocarcinoma cells under cultured conditions. Taken together, these results provided a biochemical basis underlying the metabolism of hesperetin, naringenin and apigenin through sulfation in humans.

     

Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate

trans-Resveratrol, a phenolic phytoalexin occurring in grapes, wine, peanuts, and cranberries, has been reported to both have anticarcinogenic, antioxidative, phytoestrogenic, and cardioprotective activities, and to be a weak inhibitor of cytochrome P450 (CYP)3A4, which might have significance for drug-drug interactions. Since trans-resveratrol is rapidly converted in vivo to primarily trans-resveratrol-3-sulfate, a rapid, selective, and sensitive method using liquid chromatography/tandem mass spectrometry (LC/MS/MS) was developed to investigate human cytochrome P450 inhibition by trans-resveratrol-3-sulfate. Effects of trans-resveratrol and trans-resveratrol-3-sulfate on the metabolism of selective cytochrome P450 substrates (CYP1A2/ethoxyresorufin, CYP2C9/diclofenac, CYP2C19/(S)-mephenytoin, CYP2D6/bufuralol, CYP3A4/testosterone) were monitored using cDNA-expressed human recombinant isozymes. For method validation, LC/MS/MS was used to measure the inhibition of various cytochrome P450 isozymes by different concentrations (0-50 microM) of known selective inhibitors. IC(50) values of 3.2, 1.4, 8.9, 0.2, and 0.3 microM were obtained for the standard isozyme inhibitors CYP1A2/furafylline, CYP2C9/sulfaphenazole, CYP2C19/tranylcypromine, CYP2D6/quinidine, and CYP3A4/ketoconazole, respectively, which were in good agreement with literature values. trans-Resveratrol showed IC(50) values of 11.6 microM for CYP2C19 and 1.1 microM for CYP3A4, but the IC(50) values exceeded 50 microM for all the other CYP isozymes, which indicated no inhibition. No enzyme inhibition was observed for trans-resveratrol-3-sulfate. Our results indicate that trans-resveratrol is a marginal inhibitor of CYP3A4 and a weak inhibitor of CYP2C19, but its major metabolite trans-resveratrol-3-sulfate is not an inhibitor of any of the cytochrome P450 isozymes investigated.     

UV-INDUCED REVERSION OF ADENOVIRUS 5ts2 INFECTING HUMAN CELLS

Abstract— Among the progeny produced by UV-irradiated adenovirus 5ts2 when infecting either A498 (human kidney tumor) or CRL1187 (normal human fibroblast) strains at 32° C were a certain number (UV–fluence dependent) of revertants able to grow at 39° C. Within experimental error, the induced reversion frequency was independent of whether or not the cells received UV (5 J/m²) 20 h prior to infection, indicating that induced error-prone repair was not observed in these experiments.     

Detection of exogenous intake of natural corticosteroids by gas chromatography/combustion/isotope ratio mass spectrometry: application to misuse in sport

A detailed procedure for the analysis of exogenous hydrocortisone and cortisone in urine by gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is proposed. As urinary levels of hydrocortisone are rather low for GC/C/IRMS analysis, the focus is on the main corticosteroid metabolites, tetrahydrocortisone (THE) and tetrahydrocortisol (THF). Following different solid phase extraction purifications, THE and THF are oxidized to 5beta-androstanetrione before analysis by GC/C/IRMS. Significant differences in delta(13)C per thousand values of synthetic natural corticosteroids and endogenous human corticosteroids have been observed. Therefore, a positive criterion, to detect exogenous administration of synthetic corticosteroids in anti-doping control, is proposed.     

Rapid quantification of human complement component C4A and C4B genes by capillary gel electrophoresis

Complement component 4 (C4) is an important plasma protein playing a major role in the human defense mechanism against infectious diseases and inflammatory processes. The C4A and C4B genes, encoding the two isoforms of complement 4, are located in the nuclear serine/threonine protein kinase-C4A or B gene-cytochrome 21-hydroxylase-tenascin X module (RP-C4-CYP21-TNX) and manifested by variable copy numbers among individuals between zero to six in the human diploid genome. Quantification of the C4A and C4B genes has great clinical importance since unbalanced production of C4A and C4B proteins might be associated with pathological immune processes. Albeit, high-throughput analysis methods for C4 gene dosage determination are not yet available. Here we present a novel combination of allele-specific PCR and CGE separation for rapid quantification of the C4A and C4B genes where a single-step, single-tube PCR reaction generates two allele-specific (C4A and C4B) and two control amplicons, followed by CGE analysis of the four fragments. The method presented in this paper enables automated and high-throughput gene dosage analysis of large sample cohorts.     

Simultaneous LC?CMS?CMS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study

A simultaneous simple, rapid, and sensitive LC?CMS?CMS method was developed and validated for the determination of HM30181A, [2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl]-4,5-dimethoxy-phenyl]amide, as a P-glycoprotein inhibitor and its two metabolites, M1 and M2, in human plasma using docetaxel as an internal standard (IS). The analytes were extracted from 200???L of biological sample by liquid?Cliquid extraction using 1?mL of methyl-t-butyl ether. Chromatographic separation was carried on a Luna C8 column at 30???C with mobile phase consisting of distilled water with 0.1% formic acid and acetonitrile (75:25, v/v) at a flow rate of 0.7?mL?min^?1 for human plasma samples. The method was linear over concentration ranges of 0.5?C50, 0.1?C10, and 0.1?C10?ng?mL^?1 for HM30181A, M1, and M2, respectively, in human plasma. The values of coefficient variation for the assay precision were <12.5, <9.10, and <9.96% for HM30181A, M1, and M2, respectively, in human plasma. The values of accuracy were 93.0?C108, 94.7?C104%, and 95.7?C105% for HM30181A, M1, and M2, respectively, in human plasma. This method is simple, sensitive, and applicable for the pharmacokinetic studies of HM30181A and its metabolites in humans.     

N9位芳基取代嘌呤-8-酮类衍生物的合成及抗肿瘤活性

合成了一系列N9位芳基取代嘌呤-8-酮类衍生物, 利用核磁共振氢谱(¹H NMR)、 核磁共振碳谱(¹³C NMR)和高分辨质谱(HRMS)进行了结构确证. 采用四甲基偶氮唑盐(MTT)法测定了目标化合物的体外抗肿瘤细胞增殖活性. 结果表明, 嘌呤酮环的C2位及N9位的取代对活性有较大影响, C2位引入对位由含氮六元环取代的苯胺, N9位引入对三氟甲基苯均有利于提高抗肿瘤活性. 化合物12c对人白血病细胞(K562)、 人前列腺癌细胞(PC-3)、 人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT116)的抑制效果明显优于阳性对照药R-Roscovitine.     

The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum

The detection and quantitation of apolipoproteins, important markers for coronary heart disease, in serum by liquid chromatography/tandem mass spectrometry (LC/MS/MS) using multiple reaction monitoring (MRM) is reported. A tryptic digest of depleted human serum was analysed by nanoflow LC/MS/MS at a flow rate of 300 nL/min and several apolipoproteins (Apo), including Apo A1, A2, A4, C1, C2, C3, D, F and M, were successfully identified. The analysis of the same depleted serum digest by ultra-performance (UP)LC/MS/MS operating at 700 microL/min resulted in comparable sensitivity and selectivity to the nanoflow method, but with a dramatic ( approximately 20-fold) reduction in run time. The potential of UPLC/MS/MS for the rapid quantitation of proteins in biological matrices by representative tryptic peptides was further investigated using Apo A1 and its corresponding stable isotopically labelled tryptic AQUA peptide (DYVSQFEGSALGK). A set of serum-based Apo A1 calibrators from a clinical analyser kit were digested without depletion following the addition of the AQUA peptide and analysed using UPLC/MS/MS. A linear calibration curve was generated from peak area ratios to the labelled peptide with a coefficient of correlation of 0.9989. Standard curves were also generated for other apolipoproteins together with Apo B100, Apo E, lecithin cholesterol acyltransferase and albumin, which were also detected in the standards. The concentration of Apo A1 in five fresh undepleted human serum samples and a quality control (QC) sample were determined using both the UPLC/MS/MS method and a clinical analyser. Results were comparable and the quantitative study, involving 80 injections which took hours rather than days to complete, demonstrates the high-throughput potential of UPLC/MS/MS to quantify multiple serum proteins without the need for antibodies, and thus provide an alternative to the use of clinical analysers for serum protein biomarkers.